selected scholarly activity
-
conferences
- The RADIO trial: Randomized assessment of cisplatin dosing interval for ototoxicity with curative concurrent chemo-radiation for locally advanced head and neck squamous cell carcinoma.. Journal of Clinical Oncology. TPS12144-TPS12144. 2022
- Impact of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Metastatic Disease. International Journal of Radiation Oncology Biology Physics. e479-e479. 2021
- 52: Impact of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Metastatic Disease. Radiotherapy and Oncology. S25-S25. 2021
- Treatment patterns and survival outcomes of older patients with advanced pancreatic cancer (APC): A Canadian real-world evidence study.. Journal of Clinical Oncology. 385-385. 2021
- LBA65 The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelimumab (T) as first line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC). Annals of Oncology. S1195-S1195. 2020
- Clinical outcomes of pancreas cancer patients with peritoneal spread: Results from the chord consortium.. Journal of Clinical Oncology. 2020
- The impact of primary pancreatic tumor location on clinical outcomes in advanced disease: Results from the chord consortium.. Journal of Clinical Oncology. 2020
- Abstract CT122: Randomized assessment of cisplatin dose interval for ototoxicity in the treatment of locally advanced squamous cell carcinoma of the head and neck undergoing curative concurrent chemoradiotherapy (RADIO). Cancer Research. CT122-CT122. 2019
- Abstract CT122: Randomized assessment of cisplatin dose interval for ototoxicity in the treatment of locally advanced squamous cell carcinoma of the head and neck undergoing curative concurrent chemoradiotherapy (RADIO). Clinical Trials. ct122-ct122. 2019
- Prognostic factors associated with short-term survival (STS) in advanced pancreatic cancer (APC): A Canadian multicenter analysis from the CHORD Consortium.. Journal of Clinical Oncology. e15717-e15717. 2019
- Prognostic factors associated with long term survival in chemotherapy-treated advanced pancreatic cancer: A Canadian multicenter analysis.. Journal of Clinical Oncology. 416-416. 2019
- Chemotherapy choice in advanced pancreatic cancer: What patient and disease factors influence prescription patterns?. Journal of Clinical Oncology. 327-327. 2018
- Comparative effectiveness and safety of the implementation of universal public funding of FOLFIRINOX (FFX) and gemcitabine (G) + nab-paclitaxel (GnP) in advanced pancreatic cancer (APC): A population-based study.. Journal of Clinical Oncology. 375-375. 2018
- Outcomes of FOLFIRINOX (FFX) and gemcitabine+nab-paclitaxel (GnP) in initially unresectable locally advanced pancreatic cancer (uLAPC): A population-based study.. Journal of Clinical Oncology. 394-394. 2017
- Reasons for delay in time to initiation of adjuvant chemotherapy (TTAC) for colon cancer (CC): Analysis from six academic centers in Ontario, Canada.. Journal of Clinical Oncology. 6541-6541. 2016
- Reasons for delay in time to initiation of adjuvant chemotherapy for colon cancer: A multi-institution study.. Journal of Clinical Oncology. e14504-e14504. 2014
- Cochrane systematic review and meta-analysis of adjuvant chemotherapy for stage II colon cancer. Journal of Clinical Oncology. 2013
- Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients.. Journal of Clinical Oncology. 2013
- Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients.. Journal of Clinical Oncology. e20522-e20522. 2013
- PATIENT FACTORS INVOLVED IN REFERRAL FOR LYNCH SYNDROME. Annals of Oncology. 91-91. 2012
- Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC). Journal of Clinical Oncology. 2012
- Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC).. Journal of Clinical Oncology. 2012
- CARB 31-Synthesis of S-ribosylhomocysteine analogs modified at carbon-3. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 559-559. 2007
- 2132. International Journal of Radiation Oncology Biology Physics. S284-S284. 2006
- 3-Deoxy analogues of S-ribosylhomocysteine: Targeting LuxS enzyme. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 2006
- CABG and PCI rates differ between genders even with similar coronary anatomy: A computer based patient simulation explores the gender gap. Journal of the American College of Cardiology. 266A-266A. 2006
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. Journal of Clinical Oncology. 624S-624S. 2005
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results.. Journal of Clinical Oncology. 1095S-1095S. 2005
-
journal articles
- Treatment modalities to manage hepatocellular carcinoma patients with portal vein thrombosis: a systematic review and meta-analysis. Annals of Palliative Medicine. 12:1165-1174. 2023
- Treatment Modalities to Manage Hepatocellular Carcinoma Patients with Portal Vein Thrombus: A Systematic Review and Meta-Analysis. International Journal of Radiation Oncology Biology Physics. 117:e319-e319. 2023
- Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?. Oral Oncology. 143:106444-106444. 2023
- The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review. Cancer Treatment Reviews. 118:102584-102584. 2023
- Real-world multicentre analysis of patients with hepatocellular carcinoma (HCC) treated with atezolizumab and bevacizumab (A+B): Efficacy, esophagogastroduodenoscopy (EGD) uptake and bleeding complications.. Journal of Clinical Oncology. 41:4105-4105. 2023
- Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews. 115:102526-102526. 2023
- Dosing, efficacy and safety of lenvatinb in the real‐world treatment of hepatocellular carcinoma: Results from a Canadian database. Liver Cancer International. 3:119-127. 2022
- The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma. Nature Communications. 13:5020. 2022
- Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma. JAMA network open. 5:e2222721-e2222721. 2022
- Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease. Acta Oncologica. 61:705-713. 2022
- Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.. Acta Oncologica. 61:705-713. 2022
- Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib. Hepatology. 74:1705-1707. 2021
- Non-surgical management of advanced hepatocellular carcinoma: A systematic review by Cancer Care Ontario. Canadian Liver Journal. 4:257-274. 2021
- Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Reports. 3:100260-100260. 2021
- Impact of lenvatinib (LEN) dose-intensity and starting dose on survival among patients with advanced hepatocellular carcinoma (HCC): Results from a Canadian multicenter database (HCC CHORD).. Journal of Clinical Oncology. 39:e16142-e16142. 2021
- The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective. Canadian Journal of Gastroenterology and Hepatology. 2021:1-8. 2021
- Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review. Journal of the National Cancer Institute. 113:123-136. 2021
- Efficacy and safety of lenvatinib in the real-world treatment of hepatocellular carcinoma: Results from a Canadian multicenter database (HCC CHORD).. Journal of Clinical Oncology. 39:275-275. 2021
- MRI vs. CT for the Detection of Liver Metastases in Patients With Pancreatic Carcinoma: A Comparative Diagnostic Test Accuracy Systematic Review and Meta‐Analysis. Journal of Magnetic Resonance Imaging. 53:38-48. 2021
- The addition of radiofrequency ablation for patients receiving sorafenib: new evidence for a new standard?. ANNALS OF TRANSLATIONAL MEDICINE. 9:3-3. 2021
- Evolution of Cancer Care in Response to the COVID-19 Pandemic. Oncologist. 25:e1426-e1427. 2020
- In Reply. Oncologist. 25:e1252-e1253. 2020
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 25:e936-e945. 2020
- In Reply. Oncologist. 25:E1252-E1253. 2020
- Clinical outcomes of pancreas cancer patients with peritoneal spread: Results from the chord consortium.. Journal of Clinical Oncology. 38:e19268-e19268. 2020
- Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 38:e16656-e16656. 2020
- The impact of primary pancreatic tumor location on clinical outcomes in advanced disease: Results from the chord consortium.. Journal of Clinical Oncology. 38:e19267-e19267. 2020
- Hypovascular pancreas head adenocarcinoma: CT texture analysis for assessment of resection margin status and high-risk features. European Radiology. 30:2853-2860. 2020
- Nonsurgical Management of Advanced Hepatocellular Carcinoma: A Clinical Practice Guideline. Current Oncology. 27:106-114. 2020
- Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 38:511-511. 2020
- Prognostic factors associated with short-term survival (STS) in advanced pancreatic cancer (APC): A multicenter analysis from the CHORD consortium.. Journal of Clinical Oncology. 38:650-650. 2020
- Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis. Cancer Medicine. 9:160-169. 2020
- A real-world multicenter analysis of first (1L) and second line (2L) treatment of advanced pancreatic adenocarcinoma (APC).. Journal of Clinical Oncology. 36:e16210-e16210. 2018
- A Case of Sinonasal Undifferentiated Carcinoma with Brain Metastases. Cureus. 10:e2320. 2018
- A real world multicenter study of first (1L) and second (2L) line treatment patterns and outcomes in advanced pancreatic cancer (APC).. Journal of Clinical Oncology. 36:476-476. 2018
- Simultaneous resection of colorectal cancer with synchronous liver metastases (RESECT), a pilot study. International Journal of Surgery Protocols. 8:1-6. 2018
- Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review. Journal of Otolaryngology - Head and Neck Surgery. 46:29. 2017
- Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review. Clinical Oncology. 29:459-465. 2017
- Systemic Therapy in the Curative Treatment of Head-and-Neck Squamous Cell Cancer: Cancer Care Ontario Clinical Practice Guideline. Current Oncology. 24:157-162. 2017
- Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer. Journal of Gastrointestinal Oncology. 8:32-38. 2017
- Effects of stepwise dry/wet-aging and freezing on meat quality of beef loins. Meat Science. 123:57-63. 2017
- Adjuvant Systemic Chemotherapy for Stages II and III Colon Cancer after Complete Resection: A Clinical Practice Guideline. Current Oncology. 23:418-424. 2016
- 233: Sinonasal Undifferentiated Carcinoma with Brain Metastasis: A Case Report and Review of Literature. Radiotherapy and Oncology. 120:S85-S85. 2016
- Effects of stepwise dry/wet aging on physical, chemical and quality attributes of beef loins. Meat Science. 112:136-137. 2016
- Systemic treatment patterns in small bowel and appendiceal adenocarcinomas (SBA and AA): A population-based study.. Journal of Clinical Oncology. 34:242-242. 2016
- Cochrane systematic review and meta-analysis of adjuvant therapy for stage II colon cancer.. Journal of Clinical Oncology. 33:3513-3513. 2015
- Locoregional Therapy of Locally Advanced Breast Cancer: A Clinical Practice Guideline. Current Oncology. 22:54-66. 2015
- Reasons for Delay in Time to Initiation of Adjuvant Chemotherapy for Colon Cancer: a Multi-Institution Study. Annals of Oncology. 25:iv198-iv198. 2014
- Cochrane systematic review and meta-analysis of adjuvant chemotherapy for stage II colon cancer.. Journal of Clinical Oncology. 31:3548-3548. 2013
- P-0215 Patient Factors Involved in Referral for Lynch Syndrome. Annals of Oncology. 23:iv91-iv91. 2012
- Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC).. Journal of Clinical Oncology. 30:e14001-e14001. 2012
- Is Colon Cancer Survival Influenced by Tumor Location?. Journal of Clinical Oncology. 30:1732-1733. 2012
- Chemotherapy for colorectal cancer. The Lancet Oncology. 13:e3-e4. 2012
- Coronary artery bypass graft surgery and primary percutaneous coronary intervention choices in patients with similar coronary anatomy: A computer-based simulation examines the sex gap. Canadian Journal of Cardiology. 25:649-653. 2009
- Sweet Taste in Man: A Review. Journal of Food Science. 73:R81-R90. 2008
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. Journal of Clinical Oncology. 23:LBA7012-LBA7012. 2005
- A breast-feeding assessment score to evaluate the risk for cessation of breast-feeding by 7 to 10 days of age. Journal of Pediatrics. 141:659-664. 2002
- Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole–intolerant orthotopic liver transplant patients: A preliminary study. Liver Transplantation. 7:750-751. 2001
- A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome. Intensive Care Medicine. 27:1169-1178. 2001
- Effects of oral erythrosine (2′,4′,5′,7′-tetraiodofluorescein) on thyroid function in normal men. Toxicology and Applied Pharmacology. 91:299-304. 1987